 Penumbra Inc NYSE: PEN posted Q4 FY21 revenue of 204 million, 22.2 YY up 23 in constant currency, beating the consensus of 194.30 million. Revenue from sales of vascular products grew 30.4 31.1 to 113.6 million. 